Newsfeeds - Spark Newswire

2 minute read

12 Health Care Stocks Moving In Friday’s Pre-Market Session

By Benzinga Insights

Today, 3:06 AM

AMTI

1 minute read

UPDATE: FDA CRL To Spectrum Pharmaceuticals Cited Deficiencies Related To Manufacturing And Indicated That A Reinspection Will Be Necessary

By Bill Haddad

Today, 3:06 AM

Spectrum Pharmaceuticals (NASDAQ:SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, today announced receipt of a Complete Response Letter (CRL) from the U.S. Food and Drug Administration

SPPI

1 minute read

Spectrum Pharmaceuticals Receives Complete Response Letter From FDA For ROLONTIS

By Bill Haddad

Today, 3:06 AM

SPPI

2 minute read

Movers

12 Health Care Stocks Moving In Friday’s After-Market Session

By Benzinga Insights

Today, 3:06 AM

Gainers Delcath Systems (NASDAQ:DCTH) stock increased by 8.87% to $11.9 during Friday's after-market session. This security traded at a volume of 379 shares come close, making up 0.45% of its average volume over the last 100 days. The company's market cap stands at $87.4 million.

ASLN

4 minute read

IPO Preview: Full Truck Alliance, Sprinklr, Mister Car Wash, Soulgate Lead Busy Week Of 10+ Offerings

By Chris Katje

Today, 3:06 AM

The week of June 21 is setting up to be one of the busiest IPO weeks in some time with more than dozen companies that could go public with listings. Here is a look at some of the biggest IPOs of the week with the details investors should know.

BAX

14 minute read

Uncategorized

Earnings Scheduled For May 13, 2021

By Benzinga Insights

Today, 3:06 AM

Companies Reporting Before The Bell • CASI Pharmaceuticals (NASDAQ:CASI) is estimated to report quarterly loss at $0.06 per share on revenue of $5.05 million.

AACG

6 minute read

Uncategorized

The Week Ahead In Biotech (May 9-15): Heron, Apellis FDA Decisions, Presentations and Earnings

By Shanthi Rexaline

Today, 3:06 AM

Biotech stocks came under pressure in the week ended May 7 as traders digested a slew of earnings news flow and a handful of clinical trial readouts. COVID-19 vaccine stocks came under pressure following the U.S.

ABCL